Lv1
70 积分 2024-09-08 加入
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
8小时前
待确认
Biomarkers for immunotherapy of hepatocellular carcinoma
8小时前
已完结
Nivolumab plus ipilimumab in hepatocellular carcinoma
9小时前
求助中
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
22P: Effects of datopotamab deruxtecan (Dato-DXd) vs docetaxel on patient-reported outcomes (PROs) in adults with previously treated advanced or metastatic non squamous (NSQ) non-small cell lung cancer (NSCLC): Results from TROPION-LUNG01
1个月前
已关闭
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
2个月前
已完结
Antibody–drug conjugates come of age in oncology
3个月前
已完结
Linker and Conjugation Site Synergy in Antibody–Drug Conjugates: Impacts on Biological Activity
3个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
4个月前
已完结
皖公网安备34019202002308
